90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
about
In Vivo Pretargeted Imaging of HER2 and TAG-72 Expression Using the HaloTag Enzyme.Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapyImprovement of radioimmunotherapy using pretargeting.A self-assembling short oligonucleotide duplex suitable for pretargetingComparison between two labeled agents in mice using a coinjection-ratio approach in contrast to a conventional group approach.N-acetylgalactosamino dendrons as clearing agents to enhance liver targeting of model antibody-fusion protein.Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.Development of an enzymatic pretargeting strategy for dual-modality imaging.New insights into the pretargeting approach to image and treat tumours.A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.Pretargeted Imaging and Therapy.Use of Morpholino Oligomers for Pretargeting.In vivo demonstration of an active tumor pretargeting approach with peptide nucleic acid bioconjugates as complementary system.
P2860
Q33877207-9D163DE9-416E-4A0E-8700-9A1BA00CAD6BQ36395999-154BE891-D7BB-493A-8357-D0EDA3D90D51Q36418274-0E8338DA-7B39-480F-A8FF-3966BEED864CQ36842135-DAD7227C-C725-4D72-9D11-144FB24989DFQ36941931-8039C208-1F4E-4CC3-BF44-87280625FCF9Q37044940-FD62AEF6-249B-42D4-80CD-E2AA02EB77A1Q37373494-63E46BB5-0B63-4983-8AB8-80D2B9EC318EQ37509342-6DF88877-99D7-44D8-9A88-28621D447548Q38206206-46ECB6F5-4D8D-4A56-B137-8051EA322512Q38912048-82CFF080-46C5-4D97-95AF-1FF59262B7CBQ38976879-FDC52D5E-467B-4053-B1FF-F789EA8D4DADQ39147376-BA6642F2-301E-442D-88DA-DA224B2BDC08Q39421977-8950C26D-6CA1-406B-95B5-F29A653F5BCBQ50665399-E9A0E10C-60CB-4D7F-A198-1961E57F3D86Q55093431-5A3E4068-6FE8-463B-AC0E-2E039EF48AA6
P2860
90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
@ast
90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
@en
type
label
90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
@ast
90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
@en
prefLabel
90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
@ast
90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
@en
P2093
P2860
P356
P1476
90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
@en
P2093
Donald J Hnatowich
Guozheng Liu
Mary Rusckowski
Shuping Dou
Yuzhen Wang
P2860
P304
P356
10.1021/BC200366T
P577
2011-11-03T00:00:00Z